This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ghosh, A.K.; Bilcer, G.; Harwood, C.; Kawahama, R.; Shin, D.; Hussain, K.A.; Hong, L.; Loy, J.A.; Nguyen, C.; Koelsch, G.; Ermolieff, J.; Tang, J.: Structure-based design: potent inhibitors of human brain memapsin 2 (β-secretase). J. Med. Chem., 44, 2865–2868 (2001)
Turner, R.T.; III; Loy, J.A.; Nguyen, C.; Devasamudram, T.; Ghosh, A.K.; Koelsch, G.; Tang, J.: Specificity of memapsin 1 and its implications on the design of memapsin 2 (β-secretase) inhibitor selectivity. Biochemistry, 41, 8742–8746 (2002)
Turner, R.T.; Koelsch, G.; Hong, L.; Castenheira, P.; Ghosh, A.; Tang, J.: Subsite specificity of memapsin 2 (b-secretase): implications for inhibitor design. Biochemistry, 40, 10001–10006 (2001)
Hong, L.; Turner, R.T.; Koelsch, G.; Shin, D.; Ghosh, A.K.; Tang, J.: Crystal structure of memapsin 2 (b-secretase) in complex with an inhibitor 0M00-3. Biochemistry, 41, 10963–10967 (2002)
Kennedy, M.E.; Wang, W.; Song, L.; Lee, J.; Zhang, L.; Wong, G.; Wang, L.; Parker, E.: Measuring human β-secretase (BACE1) activity using homogeneous time-resolved fluorescence. Anal. Biochem., 319, 49–55 (2003)
Hong, L.; Koelsch, G.; Lin, X.; Wu, S.; Terzyan, S.; Ghosh, A.K.; Zhang, X.C.; Tang, J.: Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor. Science, 290, 150–153 (2000)
Roggo, S.: Inhibition of BACE, a promising approach to Alzheimer’s disease therapy. Curr. Top. Med. Chem., 2, 359–370 (2002)
Ghosh, A.K.; Hong, L.; Tang, J.: β-Secretase as a therapeutic target for inhibitor drugs. Curr. Med. Chem., 9, 1135–1144 (2002)
Ermolieff, J.; Loy, J.A.; Koelsch, G.; Tang, J.: Proteolytic activation of recombinant pro-memapsin 2 (pro-β-secretase) studied with new fluorogenic substrates. Biochemistry, 39, 12450–12456 (2000)
Ehehalt, R.; Michel, B.; De Pietri Tonelli, D.; Zacchetti, D.; Simons, K.; Keller, P.: Splice variants of the β-site APP-cleaving enzyme BACE1 in human brain and pancreas. Biochem. Biophys. Res. Commun., 293, 30–37 (2002)
Luo, Y.; Bolon, B.; Damore, M.A.; Fitzpatrick, D.; Liu, H.; Zhang, J.; Yan, Q.; Vassar, R.; Citron, M.: BACE1 (β-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time. Neurobiol. Dis., 14, 81–88 (2003)
Yan, R.; Han, P.; Miao, H.; Greengard, P.; Xu, H.: The transmembrane domain of the Alzheimer’s β-secretase (BACE1) determines its late Golgi localization and access to β-amyloid precursor protein (APP) substrate. J. Biol. Chem., 276, 36788–36796 (2001)
Puglielli, L.; Ellis, B.C.; Saunders, A.J.; Kovacs, D.M.: Ceramide stabilizes β-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid β-peptide biogenesis. J. Biol. Chem., 278, 19777–19783 (2003)
Kitazume, S.; Tachida, Y.; Oka, R.; Kotani, N.; Ogawa, K.; Suzuki, M.; Dohmae, N.; Takio, K.; Saido, T.C.; Hashimoto, Y.: Characterization of α 2,6-sialyltransferase cleavage by Alzheimer’s β-secretase (BACE1). J. Biol. Chem., 278, 14865–14871 (2003)
Tomasselli, A.G.; Qahwash, I.; Emmons, T.L.; Lu, Y.; Leone, J.W.; Lull, J.M.; Fok, K.F.; Bannow, C.A.; Smith, C.W.; Bienkowski, M.J.; Heinrikson, R.L.; Yan, R.: Employing a superior BACE1 cleavage sequence to probe cellular APP processing. J. Neurochem., 84, 1006–1017 (2003)
Bruinzeel, W.; Yon, J.; Giovannelli, S.; Masure, S.: Recombinant insect cell expression and purification of human β-secretase (BACE-1) for X-ray crystallography. Protein Expr. Purif., 26, 139–148 (2002)
Beckman, M.; Holsinger, R.M.; Small, D.H.: Heparin activates β-secretase (BACE1) of Alzheimers disease and increases autocatalysis of the enzyme. Biochemistry, 45, 6703–6714 (2006)
Kimura, T.; Hamada, Y.; Stochaj, M.; Ikari, H.; Nagamine, A.; Abdel-Rahman, H.; Igawa, N.; Hidaka, K.; Nguyen, J.T.; Saito, K.; Hayashi, Y.; Kiso, Y.: Design and synthesis of potent β-secretase (BACE1) inhibitors with P1 carboxylic acid bioisosteres. Bioorg. Med. Chem. Lett., 16, 2380–2386 (2006)
von Arnim, C.A.; Kinoshita, A.; Peltan, I.D.; Tangredi, M.M.; Herl, L.; Lee, B.M.; Spoelgen, R.; Hshieh, T.T.; Ranganathan, S.; Battey, F.D.; Liu, C.X.; Bacskai, B.J.; Sever, S.; Irizarry, M.C.; Strickland, D.K.; Hyman, B.T.: The low density lipoprotein receptor-related protein (LRP) is a novel β-secretase (BACE1) substrate. J. Biol. Chem., 280, 17777–17785 (2005)
Angeletti, B.; Waldron, K.J.; Freeman, K.B.; Bawagan, H.; Hussain, I.; Miller, C.C.; Lau, K.F.; Tennant, M.E.; Dennison, C.; Robinson, N.J.; Dingwall, C.: BACE1 cytoplasmic domain interacts with the copper chaperone for superoxide dismutase-1 and binds copper. J. Biol. Chem., 280, 17930–17937 (2005)
Wong, H.K.; Sakurai, T.; Oyama, F.; Kaneko, K.; Wada, K.; Miyazaki, H.; Kurosawa, M.; De Strooper, B.; Saftig, P.; Nukina, N.: β Subunits of voltage-gated sodium channels are novel substrates of β-site amyloid precursor protein-cleaving enzyme (BACE1) and γ-secretase. J. Biol. Chem., 280, 23009–23017 (2005)
Yang, H.C.; Chai, X.; Mosior, M.; Kohn, W.; Boggs, L.N.; Erickson, J.A.; McClure, D.B.; Yeh, W.K.; Zhang, L.; Gonzalez-DeWhitt, P.; Mayer, J.P.; Martin, J.A.; Hu, J.; Chen, S.H.; Bueno, A.B.; Little, S.P.; McCarthy, J.R.; May, P.C.: Biochemical and kinetic characterization of BACE1: investigation into the putative species-specificity for β-and β-cleavage sites by human and murine BACE1. J. Neurochem., 91, 1249–1259 (2004)
Rossner, S.; Lange-Dohna, C.; Zeitschel, U.; Perez-Polo, J.R.: Alzheimers disease β-secretase BACE1 is not a neuron-specific enzyme. J. Neurochem., 92, 226–234 (2005)
Laird, F.M.; Cai, H.; Savonenko, A.V.; Farah, M.H.; He, K.; Melnikova, T.; Wen, H.; Chiang, H.C.; Xu, G.; Koliatsos, V.E.; Borchelt, D.R.; Price, D.L.; Lee, H.K.; Wong, P.C.: BACE1, a major determinant of selective vulnerability of the brain to amyloid-β amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J. Neurosci., 25, 11693–11709 (2005)
Zuechner, T.; Perez-Polo, J.R.; Schliebs, R.: β-Secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling. J. Neurosci. Res., 77, 250–257 (2004)
Hattori, C.; Asai, M.; Onishi, H.; Sasagawa, N.; Hashimoto, Y.; Saido, T.C.; Maruyama, K.; Mizutani, S.; Ishiura, S.: BACE1 interacts with lipid raft proteins. J. Neurosci. Res., 84, 912–917 (2006)
Harada, H.; Tamaoka, A.; Ishii, K.; Shoji, S.; Kametaka, S.; Kametani, F.; Saito, Y.; Murayama, S.: β-site APP cleaving enzyme 1 (BACE1) is increased in remaing neurons in Alzheimers disease brains. Neurosci. Res., 54, 24–29 (2006)
Sardana, V.; Xu, B.; Zugay-Murphy, J.; Chen, Z.; Sardana, M.; Darke, P.L.; Munshi, S.; Kuo, L.C.: A general procedure for the purification of human β-secretase expressed in Escherichia coli. Protein Expr. Purif., 34, 190–196 (2004)
Willem, M.; Garratt, A.N.; Novak, B.; Citron, M.; Kaufmann, S.; Rittger, A.; Destrooper, B.; Saftig, P.; Birchmeier, C.; Haass, C.: Control of peripheral nerve myelination by the β-secretase BACE1. Science, 314, 664–666 (2006)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2009). Memapsin 2. In: Chang, A. (eds) Class 3 Hydrolases. Springer Handbook of Enzymes, vol S6. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-85705-1_24
Download citation
DOI: https://doi.org/10.1007/978-3-540-85705-1_24
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-85704-4
Online ISBN: 978-3-540-85705-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)